Home›Companies›Biotech & Pharma›Window Therapeutics

Window Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 13, 2023·Suggest an edit

About Window Therapeutics

Window Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2021 in Delaware. It has reported $7,550,000 raised in one offering on Form D since October 2023. Its chief executive is Chih-Kao Hu.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 26, 2023Oct 13, 2023$7,550,000fully sold10$755KEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Window Therapeutics's Form D filed Oct 13, 2023.

JL
James Lu
Director
LL
Lusong Luo
Director
CH
Chih-Kao Hu
Chief Executive Officer and director

Sources

  1. SECWindow Therapeutics, Inc. filing history